Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
90,892,702
-
Share change
-
+1,062,129
-
Total reported value
-
$9,194,138,307
-
Put/Call ratio
-
169%
-
Price per share
-
$101.22
-
Number of holders
-
481
-
Value change
-
+$67,286,199
-
Number of buys
-
248
-
Number of sells
-
249
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2023
As of 31 Mar 2023,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
481 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,892,702 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bellevue Group AG, JPMORGAN CHASE & CO, JANUS HENDERSON GROUP PLC, RENAISSANCE TECHNOLOGIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MORGAN STANLEY, and Bank of New York Mellon Corp.
This page lists
481
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.